Article Text
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0099: Analysis of Gemcitabine As Second or Third Line Therapy for Recurrent Ovarian Cancer or Primary Peritoneal Cancer
Statistics from Altmetric.com
This is a PDF-only article. The first page of the PDF of this article appears above.